top of page
  • Writer's picturePhoebe Fraser

Regulator grants Cauldron Ferm license to produce animal proteins

US-based food-tech company Cauldron Ferm has had its hyper-fermentation technology approved by regulators in a “first-of-its-kind" move.

The DIR200 licence allows Cauldron to use its proprietary precision fermentation technology and Pichia Pastoris yeast, for the production of dairy, egg and spider-silk proteins.

The Office of Gene Technology Regulator (OGTR), part of the Australian Government’s Department of Health and Aged Care, found there was negligible risk based on the Risk Assessment Risk Management Plan carried out in accordance with OGTR’s Risk Analysis Framework and as a result the OGTR have deemed Cauldron’s proprietary hyper-fermentation process to be safe for use.

Cauldron CEO and co-founder, Michele Stansfield, said: “Cauldron is excited to have worked with the OGTR to achieve this first-of-a-kind license, and it is another demonstration of the readiness of Australia’s scientific ecosystem to lead biomanufacturing globally.”

Stansfield continued: “This licence significantly de-risks Australian-based precision fermentation technologies and Cauldron’s proprietary hyper-fermentation technology, giving Cauldron the confidence to rapidly erect fermentation facilities that achieve significantly lower cost of goods at a fraction of the capital expenditure.”

“Cauldron is the first in Australia to hold a licence of this nature at the 10,000-litre scale which unlocks production that all of our local synbio tech companies need to scale.”

Before companies can commercialise products using ingredients produced by Cauldron, food safety approval is required via Food Standards Australia New Zealand (FSANZ).


bottom of page